{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-097860","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.973453+00:00","generated_at":"2026-05-30T00:36:22.158505+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Envoy Medical Q3 revenue falls to $56K; FDA OKs pivotal trial for Acclaim CI","bullets":["Net revenues $56K for Q3 2024, down 30% from $80K in Q3 2023; nine-month revenues $183K, down 17%.","Cash and cash equivalents $4.4M as of Sep 30, 2024, with R&D expenses up 47% to $2.8M due to clinical prep for Acclaim CI.","FDA approved initiation of pivotal clinical study for fully implanted Acclaim Cochlear Implant (investigational, Breakthrough Device).","AMA CPT Editorial Panel approved Category III CPT codes for totally implantable middle ear hearing devices (support for Esteem FI-AMEI reimbursement).","Bipartisan House and Senate bills introduced to change CMS classification for fully implanted middle ear hearing devices for Medicare coverage."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-097860","json":"https://secwatch.observer/filing/0001213900-24-097860.json","markdown":"https://secwatch.observer/filing/0001213900-24-097860.md","text":"https://secwatch.observer/filing/0001213900-24-097860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024097860/0001213900-24-097860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024097860/ea0221085-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:36:22.158505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}